International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Evaluating the Effect of the rs2229238 and the rs4845625 Interleukin 6 Receptor Gene Polymorphisms on Body Mass Index and the Risk of Type 2 Diabetes in an Iranian Study Population

Hamid Reza Galavi 1 , Ramin Saravani 2 , * , Ali Reza Alamdari 2 , Nasrin Ranjbar 2 , Elhame Damani 3 and Tooba Nakhzari Khodakhier 4
Authors Information
1 Student Scientific Research Center, Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Cellular and Molecular Research Center, Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Department of Health Education and Promotion, School of Public Health, Zahedan University of Medical Sciences, Zahedan, IR Iran
4 Department of Biology, Sistan and Balochestan Unviersity, Sistan and Balochestan, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: December 01, 2016, 5 (4); e33289
  • Published Online: September 28, 2016
  • Article Type: Research Article
  • Received: September 22, 2015
  • Revised: January 4, 2016
  • Accepted: January 12, 2016
  • DOI: 10.5812/ijhrba.33289

To Cite: Galavi H R, Saravani R, Alamdari A R, Ranjbar N, Damani E, et al. Evaluating the Effect of the rs2229238 and the rs4845625 Interleukin 6 Receptor Gene Polymorphisms on Body Mass Index and the Risk of Type 2 Diabetes in an Iranian Study Population, Int J High Risk Behav Addict. 2016 ;5(4):e33289. doi: 10.5812/ijhrba.33289.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87(1): 4-14[DOI][PubMed]
  • 2. de Almeida-Pititto B, Dias ML, de Moraes AC, Ferreira SR, Franco DR, Eliaschewitz FG. Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab Syndr Obes. 2015; 8: 17-28[DOI][PubMed]
  • 3. 2015;
  • 4. Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011; 51(5): 993-9[DOI][PubMed]
  • 5. Saravani R, Esmaeeli E, Tamendani MK, Nejad MN. Oxytocin receptor gene polymorphisms in patients with diabetes. Gene, Cell Tissue. 2015; 2(2)
  • 6. Alberti K, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998; 15(7): 539-53
  • 7. Choi BC, Shi F. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey. Diabetologia. 2001; 44(10): 1221-31[DOI][PubMed]
  • 8. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047-53[PubMed]
  • 9. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011; 11(2): 98-107[DOI][PubMed]
  • 10. Interleukin-6 Receptor Mendelian Randomisation Analysis C, Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012; 379(9822): 1214-24[DOI][PubMed]
  • 11. Sindhu S, Thomas R, Shihab P, Sriraman D, Behbehani K, Ahmad R. Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PLoS One. 2015; 10(7): 133494[DOI][PubMed]
  • 12. Ferreira RC, Freitag DF, Cutler AJ, Howson JM, Rainbow DB, Smyth DJ, et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet. 2013; 9(4): 1003444[DOI][PubMed]
  • 13. De Filippo G, Rendina D, Moccia F, Rocco V, Campanozzi A. Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents. J Endocrinol Invest. 2015; 38(3): 339-43[DOI][PubMed]
  • 14. Wolford JK, Colligan PB, Gruber JD, Bogardus C. Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab. 2003; 80(3): 338-43[DOI][PubMed]
  • 15. Chang XW, Qin Y, Jin Z, Xi TF, Yang X, Lu ZH, et al. Interleukin-6 (IL-6) mediated the increased contraction of distal colon in streptozotocin-induced diabetes in rats via IL-6 receptor pathway. Int J Clin Exp Pathol. 2015; 8(5): 4514-24[PubMed]
  • 16. Vargas VR, Bonatto SL, Macagnan FE, Feoli AM, Alho CS, Santos ND, et al. Influence of the 48867A>C (Asp358Ala) IL6R polymorphism on response to a lifestyle modification intervention in individuals with metabolic syndrome. Genet Mol Res. 2013; 12(3): 3983-91[DOI][PubMed]
  • 17. Chu NF, Lin FH, Chin HC, Hong YJ. Association between interleukin-6 receptor gene variations and atherosclerotic lipid profiles among young adolescents in Taiwan. Lipids Health Dis. 2011; 10: 136[DOI][PubMed]
  • 18. Qi L, Rifai N, Hu FB. Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women. Diabetes. 2009; 58(1): 275-8[DOI][PubMed]
  • 19. Qi L, Rifai N, Hu FB. Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women. Diabetes. 2007; 56(12): 3075-81[DOI][PubMed]
  • 20. Horibe H, Fujimaki T, Oguri M, Kato K, Matsuoka R, Abe S, et al. Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals. Nephrology (Carlton). 2015; 20(4): 273-8[DOI][PubMed]
  • 21. Garrouste-Orgeas M, Troche G, Azoulay E, Caubel A, de Lassence A, Cheval C, et al. Body mass index. An additional prognostic factor in ICU patients. Intensive Care Med. 2004; 30(3): 437-43[DOI][PubMed]
  • 22. Bustamante M, Nogues X, Mellibovsky L, Agueda L, Jurado S, Caceres E, et al. Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur J Endocrinol. 2007; 157(5): 677-84[DOI][PubMed]
  • 23. Esteve E, Villuendas G, Mallolas J, Vendrell J, Lopez-Bermejo A, Rodriguez M, et al. Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol (Oxf). 2006; 65(1): 88-91[DOI][PubMed]
  • 24. Lin FH, Chu NF, Lee CH, Hung YJ, Wu DM. Combined effect of C-reactive protein gene SNP +2147 A/G and interleukin-6 receptor gene SNP rs2229238 C/T on anthropometric characteristics among school children in Taiwan. Int J Obes (Lond). 2011; 35(4): 587-94[DOI][PubMed]
  • 25. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001; 104(10): 1108-13[PubMed]
  • 26. Akhyani M, Ehsani AH, Robati RM, Robati AM. The lipid profile in psoriasis: a controlled study. J Eur Acad Dermatol Venereol. 2007; 21(10): 1330-2[DOI][PubMed]
  • 27. Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol. 2006; 33(3): 232-7[DOI][PubMed]
  • 28. Matsuoka R, Abe S, Tokoro F, Arai M, Noda T, Watanabe S, et al. Association of six genetic variants with myocardial infarction. Int J Mol Med. 2015; 35(5): 1451-9
  • 29. Harrison SC, Smith AJ, Jones GT, Swerdlow DI, Rampuri R, Bown MJ, et al. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. 2013; 34(48): 3707-16[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments